Press Release June 21, 2016

PRESS: Supreme Court Asks Obama Administration for Views on Biosimilar Rules (STAT)

Elaine Herrmann Blais, head of the Litigation Department in Goodwin’s Boston office, discusses the latest Supreme Court hearings on health care expenses. Blais also explains why the Court asked the Obama administration for its views on when lower-cost biosimilar medicines can be launched.

Read the full STAT article here.